DOI:
10.1055/s-00000085
The Thoracic and Cardiovascular Surgeon
LinksClose Window
References
Goodwin R, Ding K, Seymour L. et al; from the NCIC Clinical Trials Group, Kingston, Ontario, Canada.
Treatment-emergent hypertension and outcomes in patients with advanced non-small-cell lung cancer receiving chemotherapy with or without the vascular endothelial growth factor receptor inhibitor cediranib: NCIC Clinical Trials Group Study BR24.
Ann Oncol 2010;
21 (11) 2220-2226
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.